Skip to main content
OpenTrials

Clinical trial condition

Chronic Plaque Psoriasis

Explore clinical trials studying Chronic Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

46 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Chronic Plaque Psoriasis trial results

Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03412747

Conditions
Chronic Plaque Psoriasis, Moderate to Severe Plaque Psoriasis, Psoriasis, +3 more
Locations
  • Ps0008 957 Glendale, Arizona, United States
  • Ps0008 927 Los Angeles, California, United States
  • Ps0008 955 San Diego, California, United States
  • Ps0008 943 San Luis Obispo, California, United States
View all 77 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03370133

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +13 more
Locations
  • Ps0009 946 Phoenix, Arizona, United States
  • Ps0009 910 Bakersfield, California, United States
  • Ps0009 919 San Diego, California, United States
  • Ps0009 906 Boca Raton, Florida, United States
View all 105 locations
View Trial Details
Completed

Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis

NCT03897075

Conditions
Chronic Plaque Psoriasis, Moderate to Severe Nail Psoriasis
Locations
  • California Dermatology & CRI (Site 18) Encinitas, California, United States
  • First OC Dermatology (Site 07) Fountain Valley, California, United States
  • Dermatology Research Associates (Site 09) Los Angeles, California, United States
  • Clinical Science Institute (Site 14) Santa Monica, California, United States
View all 17 locations
View Trial Details
Completed

Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT03982394

Conditions
Chronic Plaque Psoriasis
Locations
  • Emiliano Baccarini Priv Practice /ID# 218581 Lomas de Zamora, Buenos Aires, Argentina
  • Hospital Universitario Austral /ID# 217540 Pilar, Buenos Aires, Argentina
  • Stringa Dermatologia /ID# 218450 Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina
  • Private Office Cristina Echeverria /ID# 222082 Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina
View all 302 locations
View Trial Details
Completed

A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)

NCT03766685

Conditions
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriasis, +3 more
Locations
  • Dv0002 946 Phoenix, Arizona, United States
  • Dv0002 910 Bakersfield, California, United States
  • Dv0002 955 San Diego, California, United States
  • Dv0002 943 San Luis Obispo, California, United States
View all 39 locations
View Trial Details
Completed

Chronic Plaque Psoriasis (Ps) Registry

NCT00799877

Conditions
Chronic Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Southview Medical Group, PC /ID# 20961 Birmingham, Alabama, United States
  • Total Skin and Beauty Derm Ctr /ID# 17156 Birmingham, Alabama, United States
  • Inverness Dermatology /ID# 76194 Birmingham, Alabama, United States
  • McLain Medical Associates, PC /ID# 18351 Birmingham, Alabama, United States
View all 339 locations
View Trial Details
Completed

Safety and Tolerability of Repeat Courses of IM Alefacept

NCT00233662

Conditions
Chronic Plaque Psoriasis
Locations
  • University of California, Irvine Irvine, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Clinical Research Specialists, Inc. Santa Monica, California, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
View all 46 locations
View Trial Details
Completed

Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

NCT04211389

Conditions
Chronic Plaque Psoriasis
Locations
  • Arcutis Biotherapeutics Clinical Site 203 Scottsdale, Arizona, United States
  • Arcutis Biotherapeutics Clinical Site 239 Beverly Hills, California, United States
  • Arcutis Biotherapeutics Clinical Site 225 Encino, California, United States
  • Arcutis Biotherapeutics Clinical Site 220 San Diego, California, United States
View all 39 locations
View Trial Details
Completed

Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

NCT04211363

Conditions
Chronic Plaque Psoriasis
Locations
  • Arcutis Biotherapeutics Clinical Site 127 Encinitas, California, United States
  • Arcutis Biotherapeutics Clinical Site 112 Fremont, California, United States
  • Arcutis Biotherapeutics Clinical Site 120 Irvine, California, United States
  • Arcutis Biotherapeutics Clinical Site 123 San Diego, California, United States
View all 40 locations
View Trial Details

Related conditions